What is DOCGO INC's earnings per share (EPS)?

DOCGO INC (DCGO) reported diluted earnings per share of $-1.84 for fiscal year 2025. This represents a -1122.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

DOCGO INC Financials

DCGO

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows DOCGO INC (DCGO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 32/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

DOCGO INC has an operating margin of -55.3%, meaning the company retains $-55 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 4.7% the prior year.

Growth

DOCGO INC's revenue declined 47.7% year-over-year, from $616.6M to $322.2M. This contraction results in a growth score of 0/100.

Leverage

100

DOCGO INC carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

DOCGO INC's current ratio of 2.26 indicates adequate short-term liquidity, earning a score of 42/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

DOCGO INC has a free cash flow margin of 9.3%, earning a moderate score of 48/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

DOCGO INC generates a -126.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 6.2% the prior year.

Piotroski F-Score Neutral

4/9

DOCGO INC passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-0.19x

For every $1 of reported earnings, DOCGO INC generates $-0.19 in operating cash flow ($34.5M OCF vs -$182.4M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$322.2M

YoY-47.7%

5Y CAGR+27.9%

DOCGO INC generated $322.2M in revenue in fiscal year 2025. This represents a decrease of 47.7% from the prior year.

EBITDA

-$162.4M

YoY-464.3%

DOCGO INC's EBITDA was -$162.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 464.3% from the prior year.

Net Income

-$182.4M

YoY-1012.4%

DOCGO INC reported -$182.4M in net income in fiscal year 2025. This represents a decrease of 1012.4% from the prior year.

EPS (Diluted)

$-1.84

YoY-1122.2%

DOCGO INC earned $-1.84 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1122.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$29.9M

YoY-55.0%

DOCGO INC generated $29.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 55.0% from the prior year.

Cash & Debt

$51.0M

YoY-42.8%

5Y CAGR+9.5%

DOCGO INC held $51.0M in cash against $184K in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

99M

YoY-3.2%

5Y CAGR+5.2%

DOCGO INC had 99M shares outstanding in fiscal year 2025. This represents a decrease of 3.2% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-55.3%

YoY-59.9pp

5Y CAGR-39.6pp

DOCGO INC's operating margin was -55.3% in fiscal year 2025, reflecting core business profitability. This is down 59.9 percentage points from the prior year.

Net Margin

-56.6%

YoY-59.9pp

5Y CAGR-40.9pp

DOCGO INC's net profit margin was -56.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 59.9 percentage points from the prior year.

Return on Equity

-126.7%

YoY-132.9pp

5Y CAGR-99.8pp

DOCGO INC's ROE was -126.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 132.9 percentage points from the prior year.

Capital Allocation

R&D Spending

$13.6M

YoY+17.0%

5Y CAGR+62.7%

DOCGO INC invested $13.6M in research and development in fiscal year 2025. This represents an increase of 17.0% from the prior year.

Share Buybacks

$10.8M

YoY-21.3%

DOCGO INC spent $10.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 21.3% from the prior year.

Capital Expenditures

$4.5M

YoY+25.8%

5Y CAGR+0.8%

DOCGO INC invested $4.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 25.8% from the prior year.

DCGO Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$322.2M-47.7%	$616.6M-1.2%	$624.3M+41.7%	$440.5M+38.2%	$318.7M+238.7%	$94.1M
Cost of Revenue	N/A	N/A	N/A	$523.9M+16.0%	$451.7M	N/A
Gross Profit	N/A	N/A	N/A	-$83.4M+37.3%	-$133.0M	N/A
R&D Expenses	$13.6M+17.0%	$11.6M+6.7%	$10.9M+101.7%	$5.4M+62.2%	$3.3M+179.1%	$1.2M
SG&A Expenses	$133.4M-3.8%	$138.8M+1.2%	$137.2M+32.6%	$103.4M+38.1%	$74.9M+114.5%	$34.9M
Operating Income	-$178.0M-720.6%	$28.7M+90.6%	$15.1M-31.0%	$21.8M+42.2%	$15.4M+204.1%	-$14.8M
Interest Expense	N/A	N/A	$1.7M+7366.6%	$23K-63.2%	$61K+287.0%	$16K
Income Tax	$8.9M-38.4%	$14.4M+130.4%	$6.2M+178.4%	-$8.0M-1393.1%	$616K+267.7%	$167K
Net Income	-$182.4M-1012.4%	$20.0M+191.5%	$6.9M-80.2%	$34.6M+45.7%	$23.7M+260.4%	-$14.8M
EPS (Diluted)	$-1.84-1122.2%	$0.18+200.0%	$0.06-82.4%	$0.34+36.0%	$0.25+200.0%	$-0.25

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$74.9M+5.8%	$70.8M-11.9%	$80.4M-16.3%	$96.0M-20.5%	$120.8M-12.9%	$138.7M-15.9%	$164.9M-14.1%	$192.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$3.8M+18.1%	$3.2M+8.0%	$3.0M-18.7%	$3.6M-1.3%	$3.7M+17.2%	$3.1M+32.8%	$2.4M-0.8%	$2.4M
SG&A Expenses	$39.2M+30.3%	$30.1M-3.7%	$31.2M-5.0%	$32.9M-6.1%	$35.0M+21.7%	$28.8M-17.2%	$34.8M-13.5%	$40.2M
Operating Income	-$104.6M-149.1%	-$42.0M-140.1%	-$17.5M-24.9%	-$14.0M-87.3%	-$7.5M-173.7%	$10.1M-0.1%	$10.1M-36.1%	$15.9M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$369K
Income Tax	$30.7M+327.4%	-$13.5M-192.0%	-$4.6M-24.3%	-$3.7M-447.5%	$1.1M-76.1%	$4.5M+21.0%	$3.7M-27.5%	$5.1M
Net Income	-$134.1M-382.8%	-$27.8M-148.9%	-$11.2M-18.6%	-$9.4M-188.3%	-$3.3M-159.3%	$5.5M-15.8%	$6.5M-41.8%	$11.2M
EPS (Diluted)	N/A	$-0.28-154.5%	$-0.11-22.2%	$-0.09	N/A	$0.05-16.7%	$0.06-40.0%	$0.10

DCGO Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$217.1M-52.4%	$455.6M-7.1%	$490.5M+24.7%	$393.3M+27.0%	$309.6M+209.1%	$100.2M
Current Assets	$152.4M-49.9%	$304.5M-10.1%	$338.9M+25.0%	$271.1M+5.9%	$256.0M+338.2%	$58.4M
Cash & Equivalents	$51.0M-42.8%	$89.2M+50.5%	$59.3M-62.3%	$157.3M-10.4%	$175.5M+441.5%	$32.4M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	$103.0M+31.4%	$78.4M+215.4%	$24.9M
Goodwill	$0-100.0%	$47.4M-0.2%	$47.5M+22.2%	$38.9M+347.8%	$8.7M+31.4%	$6.6M
Total Liabilities	$91.2M-35.0%	$140.4M-24.2%	$185.3M+62.0%	$114.4M+38.5%	$82.5M+148.4%	$33.2M
Current Liabilities	$67.5M-44.6%	$121.8M-28.4%	$170.1M+69.8%	$100.2M+73.1%	$57.9M+146.3%	$23.5M
Long-Term Debt	$184K+3425.3%	$5K-87.5%	$42K	N/A	N/A	$143K
Total Equity	$144.0M-55.1%	$320.9M+6.7%	$300.8M+10.1%	$273.2M+24.4%	$219.6M+299.3%	$55.0M
Retained Earnings	-$183.8M-13008.4%	-$1.4M+93.4%	-$21.4M+26.2%	-$29.0M+54.4%	-$63.6M+27.2%	-$87.3M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$217.1M-38.6%	$353.8M-13.3%	$408.3M-5.2%	$430.8M-5.4%	$455.6M-7.7%	$493.9M+1.2%	$488.2M-0.5%	$490.7M
Current Assets	$152.4M-19.9%	$190.2M-19.6%	$236.6M-9.9%	$262.5M-13.8%	$304.5M-7.3%	$328.3M-0.1%	$328.7M-1.9%	$335.1M
Cash & Equivalents	$51.0M-30.5%	$73.4M-29.6%	$104.2M+31.8%	$79.0M-11.5%	$89.2M-0.2%	$89.5M+35.4%	$66.1M+60.2%	$41.2M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$0-100.0%	$41.1M-17.7%	$50.0M+0.8%	$49.6M+4.5%	$47.4M-0.9%	$47.9M+0.8%	$47.5M0.0%	$47.5M
Total Liabilities	$91.2M-2.0%	$93.1M-22.7%	$120.5M-6.5%	$128.9M-8.2%	$140.4M-16.9%	$169.0M-0.7%	$170.2M-3.1%	$175.6M
Current Liabilities	$67.5M-8.3%	$73.6M-26.5%	$100.1M-6.9%	$107.6M-11.7%	$121.8M-18.9%	$150.2M-2.5%	$154.1M-3.8%	$160.1M
Long-Term Debt	$184K-6.1%	$196K	$0-100.0%	$2K-58.7%	$5K-75.6%	$21K-21.9%	$27K-19.0%	$34K
Total Equity	$144.0M-46.8%	$270.5M-9.0%	$297.3M-3.9%	$309.3M-3.6%	$320.9M-1.3%	$325.2M+3.2%	$315.2M+1.2%	$311.3M
Retained Earnings	-$183.8M-269.6%	-$49.7M-126.4%	-$22.0M-103.2%	-$10.8M-670.8%	-$1.4M-175.4%	$1.9M+151.2%	-$3.6M+64.2%	-$10.2M

DCGO Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$34.5M-50.9%	$70.1M+208.7%	-$64.5M-323.4%	$28.9M+1582.5%	-$1.9M+81.7%	-$10.7M
Capital Expenditures	$4.5M+25.8%	$3.6M-50.6%	$7.3M+128.7%	$3.2M-33.5%	$4.8M+10.2%	$4.4M
Free Cash Flow	$29.9M-55.0%	$66.5M+192.6%	-$71.8M-379.7%	$25.7M+480.0%	-$6.8M+55.0%	-$15.0M
Investing Cash Flow	-$39.1M-267.0%	-$10.7M+64.0%	-$29.6M+23.0%	-$38.4M-347.6%	-$8.6M-42.2%	-$6.0M
Financing Cash Flow	-$50.8M-110.4%	-$24.2M-2259.2%	$1.1M+118.1%	-$6.2M-104.0%	$155.2M+19211.9%	-$812K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$10.8M-21.3%	$13.8M	$0-100.0%	$3.7M	$0	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$10.5M-731.0%	$1.7M-95.1%	$33.6M+248.0%	$9.7M-24.1%	$12.7M-59.2%	$31.1M-15.6%	$36.9M+446.7%	-$10.6M
Capital Expenditures	$1.5M+70.9%	$876K+24.7%	$703K-52.2%	$1.5M+102.6%	$725K-82.9%	$4.2M-12.2%	$4.8M+406.3%	$952K
Free Cash Flow	-$12.0M-1628.9%	$783K-97.6%	$32.9M+301.9%	$8.2M-31.7%	$12.0M-55.4%	$26.9M-16.1%	$32.1M+376.7%	-$11.6M
Investing Cash Flow	-$13.1M-1289.0%	$1.1M+105.1%	-$21.4M-272.9%	-$5.7M-6.1%	-$5.4M-231.7%	-$1.6M+15.2%	-$1.9M-12.9%	-$1.7M
Financing Cash Flow	-$1.9M+94.4%	-$33.1M-347.7%	-$7.4M+13.3%	-$8.5M-8.4%	-$7.9M-6.9%	-$7.4M+8.9%	-$8.1M-815.0%	-$882K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	$0-100.0%	$5.1M-11.7%	$5.8M+114.8%	$2.7M+106.6%	$1.3M-73.6%	$4.9M+0.6%	$4.9M

DCGO Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	-18.9%+22.8pp	-41.7%	N/A
Operating Margin	-55.3%-59.9pp	4.7%+2.2pp	2.4%-2.5pp	5.0%+0.1pp	4.8%+20.5pp	-15.7%
Net Margin	-56.6%-59.9pp	3.2%+2.1pp	1.1%-6.8pp	7.8%+0.4pp	7.4%+23.2pp	-15.7%
Return on Equity	-126.7%-132.9pp	6.2%+4.0pp	2.3%-10.4pp	12.7%+1.8pp	10.8%+37.7pp	-26.9%
Return on Assets	-84.0%-88.4pp	4.4%+3.0pp	1.4%-7.4pp	8.8%+1.1pp	7.7%+22.4pp	-14.8%
Current Ratio	2.26-0.2	2.50+0.5	1.99-0.7	2.71-1.7	4.42+1.9	2.49
Debt-to-Equity	0.000.0	0.000.0	0.00-0.4	0.42+0.0	0.38+0.4	0.00
FCF Margin	9.3%-1.5pp	10.8%+22.3pp	-11.5%-17.3pp	5.8%+8.0pp	-2.1%+13.8pp	-16.0%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-139.6%-80.3pp	-59.3%-37.5pp	-21.7%-7.2pp	-14.6%-8.4pp	-6.2%-13.5pp	7.3%+1.2pp	6.2%-2.1pp	8.3%
Net Margin	-178.9%-139.7pp	-39.2%-25.4pp	-13.9%-4.1pp	-9.8%-7.1pp	-2.7%-6.7pp	4.0%0.0pp	4.0%-1.9pp	5.8%
Return on Equity	-93.1%-82.8pp	-10.3%-6.5pp	-3.8%-0.7pp	-3.0%-2.0pp	-1.0%-2.7pp	1.7%-0.4pp	2.1%-1.5pp	3.6%
Return on Assets	-61.8%-53.9pp	-7.8%-5.1pp	-2.7%-0.6pp	-2.2%-1.5pp	-0.7%-1.8pp	1.1%-0.2pp	1.3%-0.9pp	2.3%
Current Ratio	2.26-0.3	2.59+0.2	2.36-0.1	2.44-0.1	2.50+0.3	2.19+0.1	2.13+0.0	2.09
Debt-to-Equity	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.000.0	0.00
FCF Margin	-16.0%-17.1pp	1.1%-39.8pp	40.9%+32.4pp	8.5%-1.4pp	9.9%-9.5pp	19.4%-0.0pp	19.4%+25.5pp	-6.0%

Similar Companies

Biote BTMD

$48.8M

Joint Corp JYNT

$121.4M

The Oncology Institute Inc TOI

$308.4M

Cross Ctry Healthcare Inc CCRN

$295.6M

Enhabit EHAB

$710.1M

Frequently Asked Questions

What is DOCGO INC's annual revenue?

DOCGO INC (DCGO) reported $322.2M in total revenue for fiscal year 2025. This represents a -47.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is DOCGO INC's revenue growing?

DOCGO INC (DCGO) revenue declined by 47.7% year-over-year, from $616.6M to $322.2M in fiscal year 2025.

Is DOCGO INC profitable?

No, DOCGO INC (DCGO) reported a net income of -$182.4M in fiscal year 2025, with a net profit margin of -56.6%.

What is DOCGO INC's EBITDA?

DOCGO INC (DCGO) had EBITDA of -$162.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does DOCGO INC have?

As of fiscal year 2025, DOCGO INC (DCGO) had $51.0M in cash and equivalents against $184K in long-term debt.

What is DOCGO INC's operating margin?

DOCGO INC (DCGO) had an operating margin of -55.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is DOCGO INC's net profit margin?

DOCGO INC (DCGO) had a net profit margin of -56.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is DOCGO INC's return on equity (ROE)?

DOCGO INC (DCGO) has a return on equity of -126.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is DOCGO INC's free cash flow?

DOCGO INC (DCGO) generated $29.9M in free cash flow during fiscal year 2025. This represents a -55.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is DOCGO INC's operating cash flow?

DOCGO INC (DCGO) generated $34.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are DOCGO INC's total assets?

DOCGO INC (DCGO) had $217.1M in total assets as of fiscal year 2025, including both current and long-term assets.

What are DOCGO INC's capital expenditures?

DOCGO INC (DCGO) invested $4.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does DOCGO INC spend on research and development?

DOCGO INC (DCGO) invested $13.6M in research and development during fiscal year 2025.

Does DOCGO INC buy back shares?

Yes, DOCGO INC (DCGO) spent $10.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does DOCGO INC have outstanding?

DOCGO INC (DCGO) had 99M shares outstanding as of fiscal year 2025.

What is DOCGO INC's current ratio?

DOCGO INC (DCGO) had a current ratio of 2.26 as of fiscal year 2025, which is generally considered healthy.

What is DOCGO INC's debt-to-equity ratio?

DOCGO INC (DCGO) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is DOCGO INC's return on assets (ROA)?

DOCGO INC (DCGO) had a return on assets of -84.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is DOCGO INC's Piotroski F-Score?

DOCGO INC (DCGO) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are DOCGO INC's earnings high quality?

DOCGO INC (DCGO) has an earnings quality ratio of -0.19x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is DOCGO INC?

DOCGO INC (DCGO) scores 32 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.